Qaialdo

Medicinal product

(Invented) name

Qaialdo

Active substance (s)

Spironolaktonas

Strength

10 mg/ml

Pharmaceutical form

geriamoji suspensija

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03DA01, Spironolactone

Marketing authorisation holder

Nova Laboratories Ireland Limited, Airija

Date of authorisation

2023-05-26

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Oral suspension	1 ml
Spironolaktonas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111099	97210	1097210	buteliukas	150 ml N1 (buteliuko adapteris, 2 švirkštai (1 ml, 5 ml))		Receptinis	EU/1/23/1731/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-05-26	Registruotas